Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1263508 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$27,272,388
+$9,371,129 QoQ
Shares Held
4,004,756
0.0% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#17
of 208 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. TSHA ranks #44 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in TSHA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,272,388 4,004,756
2026-03-31 $17,901,259 4,004,756
2025-12-31 $22,026,158 4,004,756
2025-09-30 $13,095,552 4,004,756
2025-06-30 $9,250,986 4,004,756
2025-03-31 $5,566,610 4,004,756
2024-12-31 $6,928,227 4,004,756
2024-09-30 $8,049,559 4,004,756
2024-06-30 $8,970,653 4,004,756
2024-03-31 $11,493,649 4,004,756
2023-12-31 $7,088,418 4,004,756
2023-09-30 $7,915,028 2,504,756